This inventor holds 4 USPTO granted patents. Top assignees: Astellas Pharma Gmbh, Other. Active years: 2004-2008.
Company Filing History:
3 out of 424 
1 out of 834,411 Years Active: 2004-2008
Title: Noboru Yamaji: Innovator in Therapeutic Agents
Introduction
Noboru Yamaji is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for various diseases. With a total of 4 patents to his name, his work has the potential to impact the treatment of conditions such as type II diabetes and joint diseases.
Latest Patents
Yamaji's latest patents include a groundbreaking polypeptide that serves as a screening tool and method for therapeutic agents aimed at alleviating insulin resistance in type II diabetes. This patent discloses a novel polypeptide, a polynucleotide, a vector, a promoter, and a transformant that are essential for the screening process. Another significant patent focuses on aggrecanase, a novel polypeptide that is causative of joint diseases, particularly osteoarthritis. This patent outlines a convenient screening method for obtaining agents to treat joint diseases and details a process for manufacturing pharmaceutical compositions for these conditions.
Career Highlights
Throughout his career, Noboru Yamaji has worked with notable companies, including Astellas Pharma GmbH. His expertise in biotechnology and pharmaceuticals has allowed him to contribute to innovative solutions in the medical field.
Collaborations
Yamaji has collaborated with esteemed colleagues such as Kunitake Abe and Tetsuo Matsui. These partnerships have further enhanced his research and development efforts in creating effective therapeutic agents.
Conclusion
Noboru Yamaji's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of critical health conditions.